The structure of Plasmodium falciparum dihydrofolate reductase−thymidylate synthase, a target of clinically established antimalarial drugs, reveals the nature of inhibitor binding, drug resistance and autologous gene repression, all of which influence species-specific drug sensitivity.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
